Alcohol, ischemic heart disease, and the French paradox

Clinical Cardiology

Volumn 20, Issue 5, 1997, Pages 420-424

  Constant, Jules ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b NONE   (United States)

Author keywords

alcohol; coronary disease; flavonoids; ischemic heart disease; quercetin; resveritrol

Indexed keywords

FLAVONOID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TANNIN; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; CORONARY ARTERY DISEASE; DRUG EFFECT; FIBRINOLYSIS; FRANCE; HEART PROTECTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; MIGRAINE; REVIEW; THROMBOCYTE AGGREGATION; THROMBOGENESIS; WINE;

EID: 0030942436     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960200504     Document Type: Review

References (51)

1. Klatsky AL, Friedman GD, Siegelaub AB: Alcohol consumption before myocardial infarction: Results from the Kaiser-Permanente Epidemiologic Study of Myocardial Infarction. Ann Intern Med 1974;81/3:294-301
2. Klatsky AL, Friedman GD, Siegelaub AB, Gerard HJ: Alcohol consumption and blood pressure. Kaiser-Permanente Health Examination Data. N Engl J Med 1977;296:1154-1159
3. Dyer AR, Stamler J, Oglesby P, Berkson DM, Shekelle RB, Lepper MH, McKean H, Lindberg HA, Garside D, Tokich T: Alcohol, cardiovascular risk factors and mortality: The Chicago experience. Circulation 1981;64(suppl III):20-26
4. Howes LG, Reid JL: Decreased vascular responsiveness to noradrenaline following regular ethanol consumption. Br J Clin Pharmacol 1985;20:669-674
5. Lowry DR, Mead LA, Dannenberg AL, Klag MJ: Alcohol consumption and incidence of hypertension. The John Hopkins Precursors Study (abstr). Circulation 1995;92(8):619
6. Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson J, Witteman J, Stampfer MJ: Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 1996;27(5):1065-1072
7. Yano K, Rhoads GG, Kagan A: Coffee, alcohol, and risk of coronary heart disease among Japanese men in Hawaii. N Engl J Med 1977;297:405-409
8. Kagan A, Yano K, Rhoads GG, McGee DL: Alcohol and cardiovascular disease. The Hawaiian experience. Circulation 1981;64(suppl II):64
9. Gordon T, Kannel WB: Drinking habits and cardiovascular disease: The Framingham Study. Am Heart J 1963;105:667-673
10. Colditz GA, Branch LG, Lipnick RJ, Willett WC, Rosner B, Posner B: Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am Heart J 1985;109:886-890
11. Shaper AG, Phillips AN, Pocock SJ, Walker M: Alcohol and ischaemic heart disease in middle aged British men. Br Med J 1987;294:733-736
12. Nakamura Y, Kawai C, Kinoshita M, Moss AJ: Moderate alcohol intake and outcome after an acute coronary event. Circulation 1995;92(suppl 1):708
13. Partanen J: Patients with stable angina pectoris. Heart 1996;75(6):563-567
14. Paul O, Leppes MH, Philan WH: A longitudinal study of coronary heart disease. Circulation 1963;28:20-31
15. Doyle JT, Heslin AS, Hilleboe HE:: A prospective study of degenerative cardiovascular disease in Albany. Lancet 1966;2:553-559
16. Tibblin G, Wilhelmsen L, Werko L: Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol 1975;35:514-522
17. Hrubec Z, Cederlof R, Friberg L: Background of angina pectoris: Social and environmental factors in relation to smoking. Am J Epidemiol 1976;103:16-29
18. Hannekens CH, Rosner B, Cole DS: Daily alcohol consumption and fatal coronary heart disease (abstr). Am J Epidemiol 1978;107:197
19. Castelli WP: How many drinks a day? J Am Med Assoc 1979;242:2000
20. Evans DA, Willett WC, Hennekens CH: Alcohol and coronary heart disease. Am Heart J 1980;100:583-584
21. Stampfer MJ, Colditz GA, Willett WC: A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319:267-273
22. Taskinen M-R, Nikkila EA, Valimaki M, Sane T, Kuusi T, Kesaniemi A, Ylikahri R: Alcohol-induced changes in serum lipoproteins and in their metabolism. Am Heart J 1987;113:458-464
23. Johannson BG, Nilsson E: Alcohol consumption and HDL. N Engl J Med 1978;298:633(letter)
24. Deveny P, Robinson GM, Kapur BM, Roncari DAK: High-density lipoprotein cholesterol in male alcoholics and without severe liver disease. Am J Med 1981;71:589-594
25. Belfrage P, Berg B, Hagerstrand I: Alterations in lipid metabolism in healthy volunteers during long-term ethanol. Eur J Clin Invest 1977;7:127-131
26. Castelli WP, Hjortland MC, Kaga A, Doyle JT, Hames CG, Hulley SB, Zukel WJ: Alcohol and blood lipids. Lancet 1977;2:153-155
27. Hartung GH, Reeves RS, Foreyt JP, Patsch W, Gotto AM Jr: Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-1 in women. Am J Cardiol 1986;58:148-151
28. Moore RD, Smith CR, Kwiterovich PO, Pearson TA: Effect of low-dose alcohol use vs. abstention on plasma apoprotein A1 and B levels: A prospective, randomized trial. Circulation 1985;72(suppl III):453
29. Buring JE, Willett W, Goldhaber SZ, Mayrent SL, Breslow J, Hennekin C, and the Boston Area Health Study Research Group: Alcohol, HDL, and nonfatal MI. Circulation 1983;(suppl III):227
30. Avogaro P, Cazzolato G, Belussi F, Bittolo BG: Altered apolipoprotein composition of HDL2 and HDL3 in chronic alcoholics. Artery 1982;10:317-328
31. Haskell WL, Camargo JC, Williams PT, Vranizan KM: The effect of cessation and resumption of moderate alcohol intake on HDL subfractions. N Engl J Med 1984;310:805
32. Hendriks HF, Veenstra J, Veithuis-teWierik EJM, Schaafsma G, Kluft C: Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. Br Med J 1994;308:1003-1006
33. Evans A: Dr. Black's favourite disease. Br Heart J 1995;74:696-697
34. St. Leger AS, Cochrane AL, Moore F: Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979; 1:1017-1020
35. Artaud-Wild SM, Connor SL, Sexton G, Connor WE: Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. Circulation 1993;88:2771-2779
36. Klatsky AL, Armstrong MA: Alcoholic beverage choice and risk of coronary heart disease mortality. Am J Cardiol 1993;71:467-469
37. Gaziano JM, Godfried S, Breslow JL, Hennekens CH, Buring JE: Alcoholic beverage type, HDL, and risk of myocardial infarction. Circulation 1995;92(suppl 1):800
38. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ: Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits? Br Med J 1996;312:731-736
39. Klatsky AL, Armstrong MA, Kipp H: Correlation of alcoholic beverage preference of persons who choose wine, liquor, or beer. Br J Addiction 1990;85:1279-1289
40. Kuhnan J: The flavonoids. World Rev Nutr Diet 1976;24:117-120
41. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 1993;342:1007-1011
42. Frankel EN, Waterhouse AL, Kinsella JE: Inhibition of human LDL oxidation of resveratrol. Lancet 1993;341:1103-1104
43. Renaud S, deLorgeral M: The French paradox: Dietary factors and cigarette smoking related health problems. Ann NY Acad Sci 1993;686:299-309
44. Gronbaek M, Deis A, Sorensen TIA, Becker U, Schnohr P, Jensen G: Mortality associated with moderate intakes of wine, beer, or spirits. Br Med J 1995;310:1165-1169
45. Fuhrman B, Lavy A, Aviram M: Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995;61:549-554
46. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE: Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-457
47. Folts JD, Demrow HS, Slane PR: Two glasses of red but not white wine inhibits ex-vivo platelet aggregation and increases bleeding time in human volunteers (abstr). J Am Coll Cardiol 1994;1A:66
48. Demrow HS, Folts JD: Gastric or IV administration of French red wine but not white wine inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries (abstr). J Am Coll Cardiol 1994;1A:49
49. Pattichis K, Louca LL, Jarman J, Sandler M, Glover V: Phenolic substances in red wine and release of platelet 5-hydroxytryptamine. Lancet 1993;341:1104 (letter)
50. Ho CT, Chen Q, Shi H, Zhang KQ, Rosen RT: Antioxidative effect of various Chinese teas. Prevent Med 1992;21:520-525
51. Demrow HS, Slane PR, Folts JD: Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995;91:1182-1188